The 2nd European Carotid Surgery Trial
- Conditions
- carotid narrowingatherosclerotic carotid artery stenosis10007963
- Registration Number
- NL-OMON46858
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 200
- > 18 years of age
- symptomatic or asymptomatic atherosclerotic carotid stenosis equivalent to at least 50% measured using de NASCET method
- CAR (carotid artery risk) score < 15% 5-year risk
- clinicians are uncertain about which treatment modality is best for the individual patient
- Modified Rankin score > 2
- previous endarterectomy or stent in the randomised artery
- coronary artery bypass grafting within 3 months prior to randomisation or other major surgery within 6 weeks prior to randomisation
- coronary artery bypass grafting or other major surgery planned within 6 weeks randomisation
- pregnancy
- life expectancy of less than two years due to a pre-existing condition e.g. cancer.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Any stroke at any time, plus non-stroke death occurring within 30 days of<br /><br>revascularisation</p><br>
- Secondary Outcome Measures
Name Time Method <p>- Ipsilateral stroke<br /><br>- myocardial infarction or any hospitalisation for<br /><br>- vascular disease during follow up.<br /><br>- Disabling stroke during follow up.<br /><br>- New cerebral infarction or haemorrhage on post procedural MRI.<br /><br>- Cognitive impairment.<br /><br>- Further treatment procedure.<br /><br>- Adverse events attributed to medical treatment or CEA.<br /><br>- Quality of life and economic measures.</p><br>